<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03617653</url>
  </required_header>
  <id_info>
    <org_study_id>2018/2118</org_study_id>
    <nct_id>NCT03617653</nct_id>
  </id_info>
  <brief_title>EaRneST: Exercise and CiRulating MetabolomicS: A Pilot Randomized Controlled Study</brief_title>
  <acronym>EaRneST</acronym>
  <official_title>EaRneST: Exercise and CiRulating MetabolomicS: A Pilot Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Heart Centre Singapore</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Duke-NUS Graduate Medical School</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>National Heart Centre Singapore</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Brief Summary The purpose of this study is to investigate how circulating metabolites mediate&#xD;
      changes in heart function after exercise intervention.&#xD;
&#xD;
      Condition or disease :Cardiovascular function&#xD;
&#xD;
      Intervention/treatment Cardiovascular: Echocardiography Other: Vascular Stiffness Other:&#xD;
      Metabolomics (Blood)&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Detailed Description The purpose of the study is to determine the effect of a structured&#xD;
      exercise intervention on mitochondrial fuel metabolism and cardiovascular function.&#xD;
      Participants with diastolic dysfunction will undergo a structured exercise intervention.&#xD;
&#xD;
      Group A (intervention) will undergo exercise intervention for three months and Group B&#xD;
      (control) will not receive the exercise intervention. At the start of the study and upon&#xD;
      completion, all participants will undergo cardiovascular tests to measure cardiovascular&#xD;
      function, as well bio-specimen (blood and urine) collection for metabolic profiling.&#xD;
&#xD;
      Study Design Study Type : Randomized controlled trial Estimated Enrollment :40 participants&#xD;
      Time Perspective:Prospective Official Title:EaRneST: Exercise and CiRculating MetabolomicS: A&#xD;
      Pilot Randomized Controlled Study Study Start Date :July 2018 Estimated Primary Completion&#xD;
      Date :Nov 2019 Estimated Study Completion Date : Nov 2019&#xD;
&#xD;
      Groups and Cohorts Group/Cohort :Group A Intervention/treatment Visit 1. Baseline procedures&#xD;
&#xD;
        1. Cardiovascular measurements Arterial stiffness assessment by non-invasive brachial blood&#xD;
           pressure machine Echocardiography Standard transthoracic echocardiographic examination&#xD;
           will be performed according to established laboratory practice using standard&#xD;
           commercially available machines.&#xD;
&#xD;
           Resting electrocardiography will be performed to ascertain sinus rhythm.&#xD;
&#xD;
        2. Biospecimen collection Fresh blood, urine specimens will be collected for metabolomics.&#xD;
&#xD;
        3. Six-minute walk test The Six-Minute Walk Test is a shuttle walk test.&#xD;
&#xD;
        4. Musculoskeletal Analysis Participants will undergo focused examinations that include&#xD;
           measurement of height, weight, body mass index, waist circumference, body composition&#xD;
           analysis.&#xD;
&#xD;
      Visit 2 to Visit 13. One time per week exercise intervention for a total of three months&#xD;
&#xD;
      Visit 14: End of three months' procedures.&#xD;
&#xD;
        1. Cardiovascular measurements Echocardiography Resting electrocardiography will be&#xD;
           performed to ascertain sinus rhythm.&#xD;
&#xD;
        2. Biospecimen collection Fresh blood, urine specimens will be collected for metabolomics.&#xD;
&#xD;
        3. Six-minute walk test&#xD;
&#xD;
        4. Musculoskeletal Analysis&#xD;
&#xD;
      Group B Visit 1. Baseline procedures&#xD;
&#xD;
        1. Cardiovascular measurements Arterial stiffness assessment by non-invasive brachial blood&#xD;
           pressure machine Echocardiography Standard transthoracic echocardiographic examination&#xD;
           will be performed according to established laboratory practice using standard&#xD;
           commercially available machines.&#xD;
&#xD;
           Resting electrocardiography will be performed to ascertain sinus rhythm.&#xD;
&#xD;
        2. Biospecimen collection Fresh blood, urine specimens will be collected for metabolomics.&#xD;
&#xD;
        3. Six-minute walk test The Six-Minute Walk Test is a shuttle walk test.&#xD;
&#xD;
        4. Musculoskeletal Analysis Participants will undergo focused examinations that include&#xD;
           measurement of height, weight, body mass index, waist circumference, body composition&#xD;
           analysis.&#xD;
&#xD;
      Visit 2: End of three months' procedures.&#xD;
&#xD;
        1. Cardiovascular measurements Arterial stiffness assessment by non-invasive brachial blood&#xD;
           pressure machine Echocardiography Resting electrocardiogram will be performed to&#xD;
           ascertain heart rhythm.&#xD;
&#xD;
        2. Biospecimen collection Fresh blood, urine specimens will be collected for metabolomics.&#xD;
&#xD;
        3. Six-minute walk test&#xD;
&#xD;
        4. Musculoskeletal Analysis Outcome Measures&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 19, 2019</start_date>
  <completion_date type="Actual">November 30, 2019</completion_date>
  <primary_completion_date type="Actual">November 30, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in Metabolmic Profile</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Cardiovascular Disease Other</condition>
  <arm_group>
    <arm_group_label>Group A - Intervention</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Baseline procedure, Bio specimen collection , Six minute walk, Musculoskeletal Analysis, Exercise intervention from Visit 2 to Visit 13, End of 3 month assessment.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B- Control</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Baseline procedure, Bio specimen collection , Six minute walk, Musculoskeletal Analysis &amp; End of 3 month assessment.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Group A</intervention_name>
    <description>Refer to detailed study Description</description>
    <arm_group_label>Group A - Intervention</arm_group_label>
    <arm_group_label>Group B- Control</arm_group_label>
    <other_name>six minute walk test</other_name>
    <other_name>exercise intervention</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Aged 40 years old and above&#xD;
&#xD;
          -  At least Grade 1 Diastolic Dysfunction&#xD;
&#xD;
          -  Willing and able to give informed consent for participation for the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History of cardiovascular disease&#xD;
&#xD;
          -  History of cancer&#xD;
&#xD;
          -  History of stroke&#xD;
&#xD;
          -  Uncontrolled hypertension (systolic blood pressure ≥160mmHg and/or diastolic blood&#xD;
             pressure ≥90mmHg) despite being on treatment for hypertension&#xD;
&#xD;
          -  Low blood pressure (systolic blood pressure &lt;90mmHg or diastolic blood pressure&#xD;
             &lt;40mmHg)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Su-Mei Angela Koh, MBBS</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Heart Centre Singapore</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>National Heart Center Singapore</name>
      <address>
        <city>Singapore</city>
        <zip>169609</zip>
        <country>Singapore</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Singapore</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>July 31, 2018</study_first_submitted>
  <study_first_submitted_qc>July 31, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 6, 2018</study_first_posted>
  <last_update_submitted>April 14, 2021</last_update_submitted>
  <last_update_submitted_qc>April 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

